TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Sight Sciences Stock

Sight Sciences Stock

sightsciences.comHealthcare / Medical DevicesFounded: 2010Funding to Date: $180MM

Sight Science was created in 2010, focusing on developing and commercializing innovative solutions to transform care and improve patients' lives. Targeting eye diseases and using minimally invasive or non-invasive approaches positively impacts a patient's sight. By implementing these techniques, Sight Sciences can address the underlying causes of the world's most prevalent eye disease.

Learn more about Sight Sciences IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Sight Sciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Sight Sciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Sight Sciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Jesse Selnick
Chief Financial Officer
Shawn O'Neil
Chief Commercial Officer
Paul Badawi
Co-Founder, President, Chief Executive Officer & Board Member
David Badawi MD
Co-Founder, Chief Technology Officer & Board Member
Reay Brown
Chief Medical Officer

Board Members

David Badawi MD
Valeska Schroeder Ph.D
Mack Hicks
Hicks Equity Partners
Paul Badawi
Carter Meyer JD
Scientific Health Development
Tommy Hicks

Other companies like Sight Sciences in the Medical Devices sector

Neuralink

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$3.45B

Synchron

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$400.53MM

HistoSonics

Sector
Healthcare / Medical Devices
 
 

Levels

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$300.69MM

Eko Health

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$268.75MM

Beta Bionics

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$263MM

Imperative Care

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$1.35B

CMR Surgical

Sector
Healthcare / Medical Devices
 
 

AliveCor

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$943.68MM

News Highlights

Eyewire Today 12/09/2019
Sight Sciences Appoints Erica Rogers to its Board of Directors
Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepr
FinSMEs 09/05/2019
Sight Sciences Raises $56M in Funding | FinSMEs
Sight Sciences, a medical device company focused on ophthalmology and optometry, glaucoma and dry eye disease, closed a $31m in Series D financing

Trending Companies

Frequently Asked Questions

Updated on: Apr 19, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.